Jeffrey Hergenrather is a general practitioner specializing in cannabis/cannabinoid medicine since 1999. His medial experience includes 26 years in emergency medicine and private general practice. His involvement in the field of cannabinoid medicine date back to 1977. He continues in a consultation practice in northern California with face-to-face, telephone, and on-line consultations for the use of cannabis as medicine.
Dr. Hergenrather’s practice, research, and teaching focus on the medicinal use of cannabis through a wide range of conditions and age groups – from infants to end-of-life care. He is an adjunct professor at Sonoma State University teaching a Biology course in the Medical Use of Cannabis. He is a founding member and current president of the Society of Cannabis Clinicians, a non-profit corporation dedicated to quality patient care, education, and clinical studies. The SCC is the oldest organization of physicians specializing in the use of cannabis as medicine.
Hergenrather is a member of the International Association for Cannabinoids in Medicine (IACM), and the International Cannabinoid Research Society (ICRS). He serves as an expert witness and consultant to government and industry in supporting safe access to measured cannabis medicines.